Study on Derivatization and Biological Activity of Natural Product Daidzein

doi:10.1007/s40242-024-4102-9

Chemical Research in Chinese Universities ›› 2024, Vol. 40 ›› Issue (6): 1256-1265.doi: 10.1007/s40242-024-4102-9

• Articles • Previous Articles Next Articles

Study on Derivatization and Biological Activity of Natural Product Daidzein

LUO Zeping^1,2, PAN Liwei^1,2

1. Department of College of Chemistry and Bio-engineering, Hechi University, Hechi 546300, P. R. China;
2. Guangxi Collaborative Innovation Center of Modern Sericulture and Silk, School of Chemistry and Bioengineering, Hechi University, Hechi 546300, P. R. China

Received:2024-04-15 Online:2024-12-01 Published:2024-10-26
Contact: PAN Liwei,06048@hcnu.edu.cn E-mail:06048@hcnu.edu.cn
Supported by:
This work was supported by the 2023 Guangxi Zhuang Autonomous Region New Engineering, New Medical, New Agricultural, and New Humanities Research and Practice Project, China (No. XYK202319) and the Project of Guangxi Collaborative Innovation Center of Modern Sericulture and Silk, China (No.2022GXCSSC10).

Abstract

Abstract: A new class of Daidzein derivatives were developed, and their protective effects on neuronal cells and their mechanisms were examined. The protective effects of Daidzein derivatives against oxygen and glucose deprivation/reoxygenation (OGD/R) injury in HT22 cells were evaluated via a Cell Counting Kit 8 (CCK-8) assay. Biomarkers associated with ferroptosis, including changes in reactive oxygen species (ROS), lipid peroxidation, ferrous ion (Fe²⁺), glutathione (GSH), superoxide dismutase (SOD) and malondialdehyde (MDA) levels, were detected via fluorescent probes and specific kits. In addition, the protein expression levels of glutathione peroxidase 4 (GPX4), recombinant solute carrier family 7, member 11 (SLC7A11 or xCT) and nuclear Factor 2 (Nrf2) were analyzed via Western blotting. The newly synthesized Daidzein derivative outperforms not only its parent compound, especially derivative 3, in improving the viability of OGD/R-treated HT22 cells but also edaravone, a positive control drug. This study further revealed the mechanism of action of derivative 3: reducing the level of ROS and lipid peroxidation induced by OGD/R in HT22 cells, restoring SOD and GSH activities, reducing MDA and Fe²⁺ accumulation, and increasing the protein expression of GPX4, xCT and Nrf2. Derivative 3 has significant neuroprotective effects, and its mechanism may involve activating the Nrf2/xCT/GPX4 pathway and inhibiting neuronal ferroptosis. This study provides a new perspective for neuroprotection research and a direction for drug development.

Key words: Daidzein derivatization, Neuronal cell, Protective effect

LUO Zeping, PAN Liwei. Study on Derivatization and Biological Activity of Natural Product Daidzein[J]. Chemical Research in Chinese Universities, 2024, 40(6): 1256-1265.

References

[1] Tang X., Yan T., Wang S., Liu Q., Yang Q., Zhang Y., Li Y., Wu Y., Liu S., Ma Y., Yang L., Neural Regen Res., 2024,19, 642.
[2] Song T., Zhang Y., Zhu L., Zhang Y., Song J., Medicine, 2023, 102, e35890.
[3] Zhang L., Han Y., Wu X., Chen B., Liu S., Huang J., Kong L., Wang G., Ye Z., Apoptosis, 2023, 28, 1285.
[4] Huang J., Chen L., Yao Z. M., Sun X. R., Tong X. H., Dong S. Y., Biomed. Pharmacother, 2023, 162, 114671.
[5] Guillon B., Toulgoat F., Rev Neurol., 2014, 170, 425.
[6] Hu X., Bao Y., Li M., Zhang W., Chen C., Exp Neurol., 2023, 372, 114630.
[7] Gao J., Yao M., Zhang W., Yang B., Yuan G., Liu J. X., Zhang Y., Biomed. Pharmacother., 2022, 155, 113479.
[8] Bangar A., Khan H., Kaur A., Dua K., Singh T. G., J. Ethnopharmacol., 2024, 319, 117153.
[9] Tao Y. W., Yang L., Chen S. Y., Zhang Y., Zeng Y., Wu J. S., Meng X. L., J. Ethnopharmacol., 2022, 294, 115316.
[10] Huang P., Wan H., Shao C., Li C., Zhang L., He Y., Front. Pharmacol., 2022, 12, 688596.
[11] Yuan Q., Yuan Y., Zheng Y., Sheng R., Liu L., Xie F., Tan J., Biomed. Pharmacother., 2021, 137, 111303.
[12] Laddha A. P., Kulkarni Y. A., Phytother Res., 2023, 37, 2578.
[13] van der Eecken H., Joniau S., Berghen C., Rans K., de Meerleer G., Nutrients, 2023, 15, 4856.
[14] Kassab R. B., Elhenawy A. A., AbdulrahmanTheyab H., Hawsawi Y. M., Al-Amer O. M., Oyouni A. A. A., Habotta O. A., Althagafi H. A., Alharthi F., Lokman M. S., Alsharif K. F., Albrakati A., Al-Ghamdy A. O., Elmahallawy E. K., Elhefny M. A., Hassan K. E., Albarakati A. J. A., Abdel Moneim A. E., Moustafa A. A., Environ. Sci. Pollut Res. Int., 2023, 30, 119016.
[15] Singh S., Grewal S., Sharma N., Behl T., Gupta S., Molecules, 2023, 28, 1765.
[16] Gu Y., Chen X., Fu S., Liu W., Wang Q., Liu K.J., Shen J., Front. Pharmacol., 2021, 12, 533028.
[17] Li S., Li L., Min S., Liu S., Qin Z., Xiong Z., Xu J., Wang B., Ding D., Zhao S., J. Southern Med. University, 2023, 43, 323.
[18] Hamada H., Hamada H., Ishihara K., Kuboki A., Iwaki T., Kiriake Y., Natural Product Commun., 2021,16, 1.
[19] Ma Y., Lovekamp-Swan T., Bekele W., Dohi A., Schreihofer D. A., Endocrinology, 2013, 154, 1589.
[20] Yuan W., Chen Q., Zeng J., Xiao H., Huang Z. H., Li X., Lei Q., Neural Regen Res., 2017, 12, 235.
[21] Liu R., Zhong X., Zeng J., Huang Z., Li X., Xiao H., Chen Q., Li D., Int. J. Mol. Med., 2017, 39, 1021.
[22] Yuan J. W., Yang L. R., Mai W. P., Mao P., Wang F., Xue Y., Xiao Y. M., Qu L. B., Zeitschrift für Naturforschung B, 2015, 70, 727.
[23] Yan X., Li Y. M., Yu J., Liu H. Q., Acta Chim. Sinica, 2007, 65, 2720.
[24] Chang H., Liang R., Han R., Ai X., Zhang J., Chem. J. Chinese Universities, 2011, 38, 1150.
[25] Xiao Y. M., Zhu X. L., Yuan J. W., Yang L. R., Xu Y., Mao P., Qu L. B., Chem. Natural Compounds, 2014, 50, 76.
[26] Lu J., Gui L., Sha L., Jiang Z., Zhang J., Zhou L., Huang W., Chin. J. Organ. Chem., 2011, 76, 1852.
[27] Hong Z., Yu T. T., Yasir M., Sara M., Black D. S., Willcox M. D. P., Kuppusamy R., Kumar N., Chem. Select, 2024, 9, e202400502.
[28] Zhang Z., Liu Q., Liu X., Yang B., Duan Y., Gao Z., Yu K., Acta Chim. Sinica, 2002, 10, 1846.
[29] Zeng Q., Huang Z., Zhang J., Liu R., Li X., Zeng J., Xiao H., Front. Neurosci., 2019, 13, 104.
[30] Feng R., Luo L., Han Z., Qi Y., Xiao H., Huang C., Peng W., Liu R., Huan Z, Current Pharma. Design, 2024, 30, 1762.
[31] Wu J., Liu S., Shen X., Yang N., Liu Y., Tsuji I., Yamamura T., Li J., Li X., Chem. Res. Chinese Universities, 2013, 29, 911.
[32] Maleki F., Farahani A. M., Rezazedeh F., Sadeghzadeh N., Bioorg. Chem., 2020, 99, 103802.
[33] Xu Q., Deng H., Li X., Quan Z. S., Front Chem., 2021, 9, 650569.
[34] Chen Y., Tan S., Liu M., Li J., Scand. Cardiovasc. J., 2018, 52, 335.
[35] Yang K., Jin M. J., Quan Z. S., Piao H. R., Molecules. 2019, 24, 884.
[36] Jiang L., Xu L., Liu H., Chen H., Wang W., Crit. Rev. Immunol., 2024, 44, 77.
[37] Singh G., Kesharwani P., Kumar Singh G., Kumar S., Putta A., Modi G., Bioorg. Med. Chem., 2024, 98, 117564.
[38] Zhang X., Yang R., Wang H., Cao C., Zhao W., Duan L., Chen F., Curr. Drug Deliv., 2024, 21, 236.
[39] Zhu H., Cheng Y., Wang X., Yang X., Liu M., Liu J., Liu S., Wang H., Zhang A., Li R., Ye C., Zhang J., Gao J., Fu X., Wu B., Cell Death Dis., 2023, 14, 845.
[40] Wu H., Chen L., Lu K., Liu Y., Lu W., Jiang J., Weng C., Mediators Inflamm., 2023, 2023, 2157355.
[41] Sun X., Zhang Q., Lin X., Shu P., Gao X., Shen K., Cell Death Dis., 2023, 14, 839.
[42] Wang Y., Li P., Wang C., Bao S., Wang S., Zhang G., Zou X., Wu J., Guan Y., Ji M., Guan H., BMC Ophthalmol., 2023, 23, 514.
[43] Ruan Q., Wang C., Zhang Y., Sun J., Chem. Biol. Interact., 2023, 110835.
[44] Wen L. J., Yin J. G., Wang Y. X., Liu K., Zhao J. X., Parasit. Vectors., 2023, 16, 465.
[45] He Y., Ling Y., Zhang Z., Mertens R.T., Cao Q., Xu X., Guo K., Shi Q., Zhang X., Huo L., Wang K., Guo H., Shen W., Shen M., Feng W., Xiao P., Redox Biol., 2023, 65, 102822.
[46] Feng H., Liu Y., Gan Y., Li M., Liu R., Liang Z., Liu L., Li L., Chen H., Li G., Tian Z., Liu X., Ma S., Oxid. Med. Cell Longev., 2022, 2022, 8091464.
[47] Deng X. H., Lin B. F., Wang F., Xu P. C., Wang N. N., Phytomedicine, 2023, 155282.
[48] Li D., Song C., Song C., Tian X., Zhang H., Zhang J., Zhao X., Chem. Biol. Interact., 2023, 388, 110829.
[49] Luo X., Wang Y., Zhu X., Chen Y., Xu B., Bai X., Weng X., Xu J., Tao Y., Yang D., Du J., Lv Y., Zhang S., Hu S., Li J., Jia H., Redox Biol., 2023, 69, 102987.
[50] Huang X., Yan X., Chen G., Feng Y., Bai Y., Yan P., Lai J., Wei S., Psychopharmacology, 2024, 241, 291.

Study on Derivatization and Biological Activity of Natural Product Daidzein

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments